{"id":203137,"name":"LUPIN PHARMACEUTICALS, INC.","slug":"lupin-pharmaceuticals-inc","state":"MD","country":"United States of America","description":"Generic pharmaceutical manufacturer","totalSpending":200000,"filings":9,"yearlySpending":[{"year":2019,"income":80000},{"year":2020,"income":120000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"DEF","display":"Defense"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["GOVERNMENT COUNSEL, LLC"],"lobbyists":["HENRY MENN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["electronic drug labeling, drug take back program and USPTO inter partes review procedure.","President's Budget For A Better America (FY20202) relating to the Department of Health and Human Services generic drug exclusivity proposal.","H.R. 938-The Blocking Act; H.R. 1499-Protecting Consumer Access to Generic Drugs Act of 2019.","H.R. 938-The Blocking Act; H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs;S. 1895-Lower Health Care Costs Ac.","H.R. 938-The Blocking Act; H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs; S. 1895-Lower Health Care Costs Ac (Sec.205)."]}